|
|
|
Corporate Profile:
Dyax
| Summary: |
| Dyax
is involved in the discovery, development, and commmercialization
of fully human monoclonal antibodies as well as
small proteins and peptides. |
| Address: |
300 Technology Square
Cambridge, MA 02139 |
| Phone
#'s: |
| Main |
(617) 225-2500 |
| Human
Resources |
not known |
| Investor
Relations |
(617) 250-5744 |
| Fax
#'s: |
| Main |
(617) 225-2501 |
| Human
Resources |
not known |
| Investor
Relations |
(617) 225-2501 |
| Financial
information: |
| DYAX |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
